| Oct 25 |
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
|
| Oct 14 |
Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month
|
| Oct 9 |
Dr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy Trial
|
| Oct 9 |
Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years
|
| Oct 8 |
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
|
| Oct 8 |
Dr. Reddy’s Unveils New Danish Subsidiary
|
| Oct 2 |
Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
|
| Oct 1 |
Dr. Reddy’s Acquires Global NRT Leader Nicotinell
|
| Sep 28 |
Dr. Reddy’s Expands Portfolio with $620M Investment
|
| Aug 21 |
Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
|
